142 related articles for article (PubMed ID: 2179856)
1. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
Weinberg GA; Granoff DM
Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
[No Abstract] [Full Text] [Related]
2. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
[TBL] [Abstract][Full Text] [Related]
3. Comparative immune responses to Haemophilus influenzae type b polysaccharide and a polysaccharide-protein conjugate vaccine.
Kim KS; Wong VK; Adler R; Steinberg EA
Pediatrics; 1990 Apr; 85(4 Pt 2):648-50. PubMed ID: 2107516
[No Abstract] [Full Text] [Related]
4. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease.
Rubin LG; Voulalas D; Carmody L
Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
6. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
8. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
Weinberg GA; Murphy TV; Granoff DM
Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
[No Abstract] [Full Text] [Related]
9. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseases.
Marcinak JF; Frank AL; Labotka RL; Rao S; Drawhorn L; Dampier C; Frisone LR; Yogev R; McVerry P
J Pediatr; 1991 Jan; 118(1):69-71. PubMed ID: 1986101
[No Abstract] [Full Text] [Related]
10. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G
J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061
[No Abstract] [Full Text] [Related]
11. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.
Robbins JB; Schneerson R
N Engl J Med; 1990 Nov; 323(20):1415-6. PubMed ID: 2233910
[No Abstract] [Full Text] [Related]
12. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
[TBL] [Abstract][Full Text] [Related]
13. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
[No Abstract] [Full Text] [Related]
14. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia.
Webber SA; Sandor GG; Patterson MW; Mitchell LA; Scheifele D; Ochnio JJ; McVerry PH
J Infect Dis; 1993 May; 167(5):1210-2. PubMed ID: 8486956
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.
Weinberg GA; Granoff DM
J Pediatr; 1988 Oct; 113(4):621-31. PubMed ID: 3050001
[No Abstract] [Full Text] [Related]
16. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
[No Abstract] [Full Text] [Related]
18. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
19. Comparison of active and combined passive/active immunization of Navajo children against Haemophilus influenzae type b.
Letson GW; Santosham M; Reid R; Priehs C; Burns B; Jahnke A; Gahagan S; Nienstadt L; Johnson C; Smith D
Pediatr Infect Dis J; 1988 Nov; 7(11):747-52. PubMed ID: 3266005
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
